Plasminogen Activator Inhibitor-1 Is a Marker and a Mediator of

Biomolecules, Free Full-Text

Pharmacological inhibition of plasminogen activator inhibitor-1 prevents memory deficits and reduces neuropathology in APP/PS1 mice

Journal of Cellular Physiology, Cell Biology Journal

Plasminogen Activator Inhibitor Type 1 Deficiency

Involvement of plasminogen activator inhibitor-1 in p300/p53-mediated age-related atrial fibrosis [PeerJ]

Drug Targeting of Plasminogen Activator Inhibitor-1 Inhibits Metabolic Dysfunction and Atherosclerosis in a Murine Model of Metabolic Syndrome

Inhibition of PAI (Plasminogen Activator Inhibitor)-1 Improves Brain Collateral Perfusion and Injury After Acute Ischemic Stroke in Aged Hypertensive Rats

Type 1 plasminogen activator inhibitor as a common risk factor for cancer and ischaemic vascular disease: the EPICOR study

C-Reactive Protein Increases Plasminogen Activator Inhibitor-1 Expression and Activity in Human Aortic Endothelial Cells

Plasminogen activator inhibitor-1 in cancer research - ScienceDirect

Unbiased proteomics identifies plasminogen activator inhibitor-1 as a negative regulator of endothelial nitric oxide synthase